T
Taek Keun Nam
Researcher at Chonnam National University
Publications - 34
Citations - 703
Taek Keun Nam is an academic researcher from Chonnam National University. The author has contributed to research in topics: Chemoradiotherapy & Radiation therapy. The author has an hindex of 11, co-authored 34 publications receiving 587 citations.
Papers
More filters
Journal ArticleDOI
Pathologic complete response of primary tumor following preoperative chemoradiotherapy for locally advanced rectal cancer: long-term outcomes and prognostic significance of pathologic nodal status (KROG 09-01).
Seung Gu Yeo,Dae Yong Kim,Tae Hyun Kim,Hee Jin Chang,Jae Hwan Oh,Won Park,Doo Ho Choi,Heerim Nam,Jun Sang Kim,Moon June Cho,Jong Hoon Kim,Jin-Hong Park,Min Kyu Kang,Woong Sub Koom,Jae Sung Kim,Taek Keun Nam,Eui Kyu Chie,Jung Soo Kim,Kyung Ja Lee +18 more
TL;DR: LARC patients achieving ypT0N0 after preoperative CRT had favorable long-term outcomes, whereas positive ypN status had a poor prognosis even after total regression of primary tumor.
Journal ArticleDOI
Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study
Seok Jin Kim,Deok Hwan Yang,Jin Seok Kim,Jae Yong Kwak,Hyeon Seok Eom,Dae Sik Hong,Jong Ho Won,Jae Hoon Lee,Dok Hyun Yoon,Jaeho Cho,Taek Keun Nam,Sang-wook Lee,Yong Chan Ahn,Cheolwon Suh,Won Seog Kim +14 more
TL;DR: CCRT followed by l-asparaginase-containing chemotherapy is a feasible treatment for newly diagnosed stages IE/IIE nasal ENKTL and grade III or IV hematologic toxicity was frequent during VIDL chemotherapy, no treatment-related mortality was observed, and l- asparaginases-associated toxicity was manageable.
Journal ArticleDOI
A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea.
Jinsil Seong,Ik Jae Lee,Su Jung Shim,Do Hoon Lim,Tae Hyun Kim,Jong Hoon Kim,Hong Seok Jang,Mi Sook Kim,Eui Kyu Chie,Jinhee Kim,Taek Keun Nam,Hyung Sik Lee,Chul Joo Han +12 more
TL;DR: To determine the national practice processes of care and outcomes of radiotherapy for hepatocellular carcinoma (HCC) in Korea, a large number of patients are diagnosed with the disease each year.
Journal ArticleDOI
Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area.
Jung Ho Im,Sang Min Yoon,Hee Chul Park,Jong Hoon Kim,Jeong Il Yu,Tae Hyun Kim,Jun Won Kim,Taek Keun Nam,Kyubo Kim,Hong Seok Jang,Jinhee Kim,Mi Sook Kim,Won Sup Yoon,Inkyung Jung,Jinsil Seong +14 more
TL;DR: This nationwide, multicenter study investigated treatment outcomes as well as the optimal radiotherapeutic strategy in patients with hepatocellular carcinoma (HCC) and portal vein tumour thrombosis (PVTT).
Journal ArticleDOI
Timely tumor response analysis after preoperative chemoradiotherapy and curative surgery in locally advanced rectal cancer: A multi-institutional study for optimal surgical timing in rectal cancer.
Yoo Kang Kwak,Kyubo Kim,Jong Hoon Lee,Sung Hwan Kim,Hyeon Min Cho,Dae Yong Kim,Tae Hyun Kim,Sun-Young Kim,Ji Yeon Baek,Jae Hwan Oh,Taek Keun Nam,Mee Sun Yoon,Jae-Uk Jeong,Eui Kyu Chie,Hong Seok Jang,Jae Sung Kim +15 more
TL;DR: The optimal timing for curative surgery in rectal cancer when tumor response is maximal is after 7weeks and before 10weeks following preoperative CRT, which is significantly higher in the delayed arm than the early arm.